Literature DB >> 223536

Liver disease associated with chronic arsenic ingestion.

J L Cowlishaw, E J Pollard, A E Cowen, L W Powell.   

Abstract

The association of chronic liver disease with long-standing arsenic ingestion is well documented, although the spectrum and incidence of liver disease due to arsenic remain uncertain. We report two patients with chronic liver disease and arsenical skin changes that followed previous chronic arsenic ingestion. One patient developed macronodular cirrhosis and the other non-cirrhotic portal hypertension with perisinusoidal fibrosis. The latter patient developed a primary liver cell cancer. There is only one previously reported case of malignant hepatoma in a non-cirrhotic liver complicating chronic arsenicism. Lack of awareness of this uncommon but well described cause of chronic liver disease may account for a small proportion of patients with "cryptogenic" liver disease. Previous arsenic administration should be considered as a cause of chronic liver disease, especially when typical skin changes or internal neoplasia develop.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 223536     DOI: 10.1111/j.1445-5994.1979.tb04146.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN: 0004-8291


  3 in total

1.  Arsenic distribution and neurochemical effects in peroral sodium arsenite exposure of rats.

Authors:  S Valkonen; H Savolainen; J Järvisalo
Journal:  Bull Environ Contam Toxicol       Date:  1983-03       Impact factor: 2.151

2.  Medicinal arsenic and internal malignancies.

Authors:  J Cuzick; S Evans; M Gillman; D A Price Evans
Journal:  Br J Cancer       Date:  1982-06       Impact factor: 7.640

3.  Cytoprotective Activity of Glycyrrhizae radix Extract Against Arsenite-induced Cytotoxicity.

Authors:  Sang Chan Kim; Sook Jahr Park; Jong Rok Lee; Jung Cheol Seo; Chae Ha Yang; Sung Hui Byun
Journal:  Evid Based Complement Alternat Med       Date:  2008-06       Impact factor: 2.629

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.